Healthcare - Biotechnology - NASDAQ - US
$ 13.31
-7.05 %
$ 1.34 B
Market Cap
-13.72
P/E
INCOME STATEMENT
0
REVENUE
-206 M
OPERATING INCOME
-189 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Day One Biopharmaceuticals, Inc.
| Revenue | 0 |
| Cost Of Revenue | 383 K |
| Gross Profit | -383 K |
| Operating Expenses | 206 M |
| Operating Income | -206 M |
| Other Expenses | -17.1 M |
| Net Income | -189 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 0.4 | 0.5 | 0.2 | 0.2 | 0 |
| Gross Profit | (0.4) | (0.5) | (0.2) | (0.2) | 0 |
| OPERATING INCOME | |||||
| Operating Expenses | 206.1 | 146.9 | 72.7 | 13.8 | 14.9 |
| Selling, General and Administrative Expenses | 75.5 | 61.3 | 29.2 | 4.7 | 1.0 |
| Research and Development Expenses | 130.5 | 85.6 | 43.6 | 9.1 | 13.9 |
| Operating Income | (206.1) | (146.9) | (72.7) | (13.8) | (14.9) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0 | 4.7 | 4 K | 30 K | 2.1 |
| Total Other Income | 17.1 | 4.7 | 11 K | (30.1) | (2.1) |
| Pre-Tax Income | (188.9) | (142.2) | (72.8) | (43.8) | (17.0) |
| NET INCOME | |||||
| Tax Provision | 0 | (10.0) | (2.3) | (3.3) | (2.3) |
| Net Income | (188.9) | (132.2) | (70.4) | (40.5) | (14.7) |
| EPS | 2.37 | 2.02 | 1.14 | 0.65 | 0.24 |